IDM Pharma, Inc. (NASDAQ:IDMI)

CAPS Rating: No stars

A biopharmaceutical company focused on developing innovative products to treat and control cancer while maintaining the patient's quality of life.

Recs

0
Player Avatar bdbartle (28.72) Submitted: 4/4/2007 10:38:08 AM : Outperform Start Price: $8.81 IDMI Score: -67.47

Sure. Why not.

Report this Post Reply

Featured Broker Partners


Advertisement